Expertise in
22
conditions

Dr. Eila C. Skinner

Urology
Interventional Radiology In San Jose
2589 Samaritan Dr, 
San Jose, CA 
Offers Telehealth
Expertise in
22
conditions
Interventional Radiology In San Jose
2589 Samaritan Dr, 
San Jose, CA 

Overview

Eila Skinner is a Urologist practicing medicine in San Jose, California.

Dr. Skinner is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

She is actively involved in clinical research, co-authoring 88 peer reviewed articles and participating in 6 clinical trials.

Specialties

Urology

Licenses

Urology in CA

Hospital Affiliations

Stanford Health Care Tri-Valley
Stanford Health Care

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Interventional Radiology In San Jose
2589 Samaritan Dr, San Jose, CA 95124
Other Locations
Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER
PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER
Enrollment Status: Active_not_recruiting
Publish Date: July 15, 2026
Intervention Type: Other, Radiation, Biological, Drug
Study Drugs: Bacillus of Calmette-Guerin, Durvalumab
Study Phase: Phase 1/Phase 2
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2026
Intervention Type: Procedure, Other
Study Phase: Not Applicable
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Methotrexate, Vinblastine, Doxorubicin, Filgrastim
Study Phase: Phase 2
View 5 Less Clinical Trials

88 Total Publications

Large multicenter validation of urine RNA profile for urothelial carcinoma detection and surveillance.
Large multicenter validation of urine RNA profile for urothelial carcinoma detection and surveillance.
Journal: The Journal of clinical investigation
Published: December 03, 2025
Similar Doctors
Expertise in
43
conditions
Expertise in
43
conditions
Referral may be required

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (17.2 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Benjamin Chung is a Urologist practicing medicine in Palo Alto, California. Dr. Chung is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Cystectomy.

Expertise in
37
conditions
Expertise in
37
conditions
Referral required
Before you request

Office

420 Broadway St Ste D21, 
Redwood City, CA 
 (21.3 miles away)
650-721-2700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Craig Comiter is a Urologist practicing medicine in Redwood City, California. Dr. Comiter is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Bladder Outlet Obstruction, Frequent or Urgent Urination, Sacral Nerve Stimulation, and Aquablation. Dr. Comiter is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral required
Before you request

Office

751 S Bascom Ave Bldg Q, 
San Jose, CA 
 (4.4 miles away)
408-793-2560
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Elliott is a Urologist practicing medicine in San Jose, California. Dr. Elliott is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, Urinary Incontinence, Urinary Tract Infection (UTI), Ureteroscopy, and Lithotripsy. Dr. Elliott is currently accepting new patients.

Frequently Asked Questions about Dr. Eila C. Skinner

How do I make an appointment with Dr. Eila C. Skinner?

You can book an appointment with Dr. Eila C. Skinner by calling their office at 408-426-4900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eila C. Skinner a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eila C. Skinner is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eila C. Skinner specialize in?

While Dr. Eila C. Skinner is a Urology, they have specific expertise in Bladder Cancer, Cystectomy, and Urothelial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Eila C. Skinner participate in research or clinical trials?

Yes. Dr. Eila C. Skinner has published 88 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Eila C. Skinner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eila C. Skinner accept my insurance?

Dr. Eila C. Skinner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 408-426-4900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Skinner's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile